Search Results

You are looking at 1 - 10 of 1,654 items for :

  • "diagnosis" x
Clear All
Full access

Therese B. Bevers, Benjamin O. Anderson, Ermelinda Bonaccio, Sandra Buys, Mary B. Daly, Peter J. Dempsey, William B. Farrar, Irving Fleming, Judy E. Garber, Randall E. Harris, Alexandra S. Heerdt, Mark Helvie, John G. Huff, Nazanin Khakpour, Seema A. Khan, Helen Krontiras, Gary Lyman, Elizabeth Rafferty, Sara Shaw, Mary Lou Smith, Theodore N. Tsangaris, Cheryl Williams and Thomas Yankeelov

Breast Cancer Screening and Diagnosis Clinical Practice Guidelines in Oncology NCCN Categories of Evidence and Consensus Category 1: The recommendation is based on high-level evidence (e.g., randomized controlled trials) and there is

Full access

Therese B. Bevers, Mark Helvie, Ermelinda Bonaccio, Kristine E. Calhoun, Mary B. Daly, William B. Farrar, Judy E. Garber, Richard Gray, Caprice C. Greenberg, Rachel Greenup, Nora M. Hansen, Randall E. Harris, Alexandra S. Heerdt, Teresa Helsten, Linda Hodgkiss, Tamarya L. Hoyt, John G. Huff, Lisa Jacobs, Constance Dobbins Lehman, Barbara Monsees, Bethany L. Niell, Catherine C. Parker, Mark Pearlman, Liane Philpotts, Laura B. Shepardson, Mary Lou Smith, Matthew Stein, Lusine Tumyan, Cheryl Williams, Mary Anne Bergman and Rashmi Kumar

clinical finding such as a palpable mass; and (2) incremental imaging after a possible abnormal screening mammogram in an asymptomatic woman (also referred NCCN Clinical Practice Guidelines in Oncology : Breast Cancer Screening and Diagnosis, Version 3

Full access

Melinda L. Telli, Kathleen C. Horst, Alice E. Guardino, Frederick M. Dirbas and Robert W. Carlson

– 355 . 7. Parker SJ Harries SA . Phyllodes tumours . Postgrad Med J 2001 ; 77 : 428 – 435 . 8. Jacklin RK Ridgway PF Ziprin P . Optimising preoperative diagnosis in phyllodes tumour of the breast . J Clin Pathol 2006 ; 59

Full access

Reith R. Sarkar, Katherine E. Fero, Daniel M. Seible, Neil Panjwani, Rayna K. Matsuno and James D. Murphy

diagnosis through death, which allows for assessment of patterns of care and hospitalizations over the entire course of a patient’s disease. Study Population A total of 32,475 patients aged ≥66 years diagnosed with histologically confirmed malignant

Full access

Kshama Jaiswal, Madelyne Hull, Anna L. Furniss, Reina Doyle, Natalia Gayou and Elizabeth Bayliss

Delays in breast cancer care can result in patient dissatisfaction as well as increased risks of local recurrence and death. 1 – 3 However, no studies have examined the full continuum of care, from presentation to imaging, to diagnosis, to

Full access

Lauren Nye, Timothy K. Huyck and William J. Gradishar

physicians perceive the diagnosis to be one that puts the life of the mother at odds with that of the fetus, but available data suggest that termination of the pregnancy does not improve the outcome for pregnant women with breast cancer. 4 Often diagnosis is

Full access

Harubumi Kato

. Kato shares a backward glance at where PDT has come from and a forward glimpse at where it may be heading. The Birth of Fluorescence Bronchoscopy for Diagnosing Lung Cancer The diagnosis of lung cancer was significantly enhanced by the development

Full access

Andrew M. Moon, Hanna K. Sanoff, YunKyung Chang, Jennifer L. Lund, A. Sidney Barritt IV, Paul H. Hayashi and Karyn B. Stitzenberg

& Population Health Resource. 18 This subset consisted of patients with continuous healthcare enrollment in any health plan for 12 months preceding and 12 months after diagnosis (or death). Patients participating in a Medicare HMO/Advantage plan were excluded

Full access

Brian J. Williams, Daniel M.S. Raper, Erin Godbout, T. David Bourne, Daniel M. Prevedello, Amin B. Kassam and Deric M. Park

extent of surgical resection and surgical margins. This article reviews the epidemiology, pathogenesis, presentation, diagnosis, and management of chordoma, and highlights future directions for potential therapy. Epidemiology Chordoma is a rare

Full access

Danielle N. Blunt, Liam Smyth, Chenthila Nagamuthu, Evgenia Gatov, Ruth Croxford, Lee Mozessohn and Matthew C. Cheung

with >15 days from diagnosis to treatment initiation (DTI) had lower-risk characteristics and improved event-free survival (EFS) at 24 months from diagnosis compared with patients treated more urgently. Furthermore, a retrospective, observational study